ofloxacin has been researched along with Acquired Immunodeficiency Syndrome in 6 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The classic histologic presentation of bacillary angiomatosis involves three components: a lobular proliferation of capillaries with enlarged endothelial cells, neutrophilic debris, and clumps of finely granular material identified as bacteria with staining techniques." | 1.33 | Bacillary angiomatosis associated with pseudoepitheliomatous hyperplasia. ( Amsbaugh, S; Huiras, E; Wang, NS; Warren, S; Wever, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelley, CF | 1 |
| Armstrong, WS | 1 |
| Eaton, ME | 1 |
| Amsbaugh, S | 1 |
| Huiras, E | 1 |
| Wang, NS | 1 |
| Wever, A | 1 |
| Warren, S | 1 |
| Maranetra, KN | 1 |
| el-Chaar, GM | 1 |
| Schwenk, MH | 1 |
| Bardini, J | 1 |
| Caliendo, G | 1 |
| Frank, C | 1 |
| Profeta, LM | 1 |
| Talbot, KA | 1 |
| Cohen, H | 1 |
| Nozaki-Renard, J | 1 |
| Iino, T | 1 |
| Sato, Y | 1 |
| Marumoto, Y | 1 |
| Ohta, G | 1 |
| Furusawa, M | 1 |
2 reviews available for ofloxacin and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Treatment of multidrug-resistant tuberculosis in Thailand.
Topics: Acquired Immunodeficiency Syndrome; Ambulatory Care Facilities; Clinical Trials as Topic; Drug Resis | 1996 |
New drugs on the horizon.
Topics: Acquired Immunodeficiency Syndrome; Aminosalicylic Acids; Antibodies, Monoclonal; Antibodies, Monocl | 1992 |
4 other studies available for ofloxacin and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Disseminated Mycobacterium haemophilum infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-HIV Agents; Cellulitis; Clarithromyc | 2011 |
Bacillary angiomatosis associated with pseudoepitheliomatous hyperplasia.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Angiomatosis, Bacillary; | 2006 |
Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity.
Topics: Acquired Immunodeficiency Syndrome; Cell Line; Cell Survival; Ciprofloxacin; Enoxacin; HIV-1; Humans | 1990 |
[Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combinati | 1989 |